Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Baumann

Showing results (291-300 of 366) with videos related to

Pageof 37
Sort By:
Brachytherapy|July 7, 2020
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancerBenjamin W Fischer-Valuck, Yuan James Rao, Randall J Brenneman, et al.
Advances in Radiation Oncology|March 29, 2024
A Prospective Phase I/II Clinical Trial of High-Dose Proton Therapy for Chordomas and ChondrosarcomasSana S Dastgheyb, Alexandra D Dreyfuss, Michael J LaRiviere, et al.
Theranostics|November 24, 2021
Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopesNadia Benabdallah, William Scheve, Nicholas Dunn, et al.
Clinical and Translational Radiation Oncology|June 17, 2021
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysisAmit Roy, Randall J Brenneman, Jacob Hogan, et al.
American Journal of Medical Genetics|April 29, 1998
CHARGE syndrome: report of 47 cases and reviewA L Tellier, V Cormier-Daire, V Abadie, et al.
Clinical and Translational Radiation Oncology|August 2, 2023
Initial clinical experience building a dual CT- and MR-guided adaptive radiotherapy programAlex T Price, Joshua P Schiff, Eric Laugeman, et al.
Journal of Surgical Oncology|June 27, 2020
Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicityBrian C Baumann, Karen De Amorim Bernstein, Thomas F DeLaney, et al.
Plos Medicine|December 14, 2021
Correction: Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort studyPradeep S Chauhan, Kevin Chen, Ramandeep K Babbra, et al.
Plos Medicine|August 31, 2021
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort studyPradeep S Chauhan, Kevin Chen, Ramandeep K Babbra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 21, 2023
Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate CancerNadia Benabdallah, Peng Lu, Diane S Abou, et al.
Pageof 37

Showing results (291-300 of 366) with videos related to

Sort By:
Pageof 37
Brachytherapy|July 7, 2020
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancerBenjamin W Fischer-Valuck, Yuan James Rao, Randall J Brenneman, et al.
Advances in Radiation Oncology|March 29, 2024
A Prospective Phase I/II Clinical Trial of High-Dose Proton Therapy for Chordomas and ChondrosarcomasSana S Dastgheyb, Alexandra D Dreyfuss, Michael J LaRiviere, et al.
Theranostics|November 24, 2021
Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopesNadia Benabdallah, William Scheve, Nicholas Dunn, et al.
Clinical and Translational Radiation Oncology|June 17, 2021
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysisAmit Roy, Randall J Brenneman, Jacob Hogan, et al.
American Journal of Medical Genetics|April 29, 1998
CHARGE syndrome: report of 47 cases and reviewA L Tellier, V Cormier-Daire, V Abadie, et al.
Clinical and Translational Radiation Oncology|August 2, 2023
Initial clinical experience building a dual CT- and MR-guided adaptive radiotherapy programAlex T Price, Joshua P Schiff, Eric Laugeman, et al.
Journal of Surgical Oncology|June 27, 2020
Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicityBrian C Baumann, Karen De Amorim Bernstein, Thomas F DeLaney, et al.
Plos Medicine|December 14, 2021
Correction: Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort studyPradeep S Chauhan, Kevin Chen, Ramandeep K Babbra, et al.
Plos Medicine|August 31, 2021
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort studyPradeep S Chauhan, Kevin Chen, Ramandeep K Babbra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 21, 2023
Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate CancerNadia Benabdallah, Peng Lu, Diane S Abou, et al.
Pageof 37